EZR and astrocytoma (excluding glioblastoma): Results from our study may greatly facilitate the development of potential therapeutic targets for astrocytoma patients, and further investigations on the roles of ezrin, miRNA-204-5p, and DNA methylation in astrocytoma are needed.